Cargando…
Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial
OBJECTIVE: Randomized treatment comparing an intensive glycemic treatment strategy with a standard strategy in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial was ended early because of an unexpected excess of mortality in the intensive arm. As part of ongoing post hoc analyses...
Autores principales: | Riddle, Matthew C., Ambrosius, Walter T., Brillon, David J., Buse, John B., Byington, Robert P., Cohen, Robert M., Goff, David C., Malozowski, Saul, Margolis, Karen L., Probstfield, Jeffrey L., Schnall, Adrian, Seaquist, Elizabeth R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858202/ https://www.ncbi.nlm.nih.gov/pubmed/20427682 http://dx.doi.org/10.2337/dc09-1278 |
Ejemplares similares
-
Intensive Glycemic Control Is Not Associated With Fractures or Falls in the ACCORD Randomized Trial
por: Schwartz, Ann V., et al.
Publicado: (2012) -
Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: Secondary analysis of the ACCORD clinical trial data
por: Bonds, Denise E, et al.
Publicado: (2012) -
Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial
por: Margolis, Karen L., et al.
Publicado: (2014) -
The Impact of Frequent and Unrecognized Hypoglycemia on Mortality in the ACCORD Study
por: Seaquist, Elizabeth R., et al.
Publicado: (2012) -
Insulin Dose and Cardiovascular Mortality in the ACCORD Trial
por: Siraj, Elias S., et al.
Publicado: (2015)